Product Information
VENLAFAXINE HCL ER 150 MG CAP is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1169 per EA under NDC 70710170000. Its NADAC has been published 113 times since May 1, 2024.
Strength
150 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710170000
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090174On Market Since
5/18/2023
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 150 MG CAP has been published 113 times since May 1, 2024, and over the history we have for it it has declined 4.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1169 per EA |
|---|---|
| All-time high | $0.1417 (Jul 10, 2024) |
| All-time low | $0.1057 (Nov 20, 2024) |
| 52-week high | $0.1341 |
| 52-week low | $0.1169 |
| Median price | $0.1293 |
| Average price | $0.1272 |
| Largest weekly change | +21.6% (Aug 21, 2024) |
| Weeks tracked | 113 |
| Tracking since | May 1, 2024 |
Generic Alternatives
The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 150 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 150 MG CAP, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1169 per EA (NDC 70710170000), effective Jun 24, 2026.
How has the price of VENLAFAXINE HCL ER 150 MG CAP changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 150 MG CAP has declined 4.8%. It has been tracked across 113 weekly CMS publications since May 1, 2024.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 150 MG CAP?
Since May 1, 2024, the NADAC for VENLAFAXINE HCL ER 150 MG CAP has ranged from a low of $0.1057 (Nov 20, 2024) to a high of $0.1417 (Jul 10, 2024), with a median of $0.1293 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 150 MG CAP?
11 NADAC-published products share the same active ingredient, strength, and dosage form as VENLAFAXINE HCL ER 150 MG CAP, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL ER 150 MG CAP?
VENLAFAXINE HCL ER 150 MG CAP (NDC 70710170000) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification